CME

CME


Multidisciplinary Perspectives in Advanced HCC: A Focus on Immune Checkpoint Inhibitors

November 17, 2020

Host: Robert Mocharnuk, MD

Guest: Richard S. Finn, MD

Guest: Amit Singal, MD, MS

The majority of patients with HCC have advanced disease at diagnosis and aren’t candidates for potentially curative treatment options, such as resection, liver trans